These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25783051)

  • 1. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
    Wang M; Deng X; Ying Q; Jin T; Li M; Liang C
    Biochem Biophys Res Commun; 2015 May; 460(2):354-61. PubMed ID: 25783051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microRNA expression signature predicts meningioma recurrence.
    Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
    Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.
    Fan SY; Jiang JD; Qian J; Lu YC; Hu GH; Luo C; Hou WD; Wang Q
    PLoS One; 2015; 10(5):e0125661. PubMed ID: 25993541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
    Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
    Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
    Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO
    Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High thioredoxin reductase 1 expression in meningiomas undergoing malignant progression.
    Esen H; Feyzioglu B; Erdi F; Keskin F; Kaya B; Demir LS
    Brain Tumor Pathol; 2015 Jul; 32(3):195-201. PubMed ID: 25592259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
    Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z
    J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
    Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
    Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00702/miR-4652-3p/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt/β-catenin pathway.
    Li T; Ren J; Ma J; Wu J; Zhang R; Yuan H; Han X
    Biomed Pharmacother; 2019 May; 113():108718. PubMed ID: 30849635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas.
    He J; Liu C; Wang B; Li N; Zuo G; Gao D
    Int J Oncol; 2015 Oct; 47(4):1503-11. PubMed ID: 26315299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma.
    Zhi F; Shao N; Li B; Xue L; Deng D; Xu Y; Lan Q; Peng Y; Yang Y
    Sci Rep; 2016 Aug; 6():32067. PubMed ID: 27558167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
    Zhu Z; Xu Y; Du J; Tan J; Jiao H
    J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
    Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
    J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT2 expression in histopathologic grading and recurrence of meningiomas.
    Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C
    Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cyclin D1 in meningioma is associated with malignancy grade and causes abnormalities in apoptosis, invasion and cell cycle progression.
    Cheng G; Zhang L; Lv W; Dong C; Wang Y; Zhang J
    Med Oncol; 2015 Jan; 32(1):439. PubMed ID: 25502086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma.
    Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT
    World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
    Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.